Hepion Pharmaceuticals, Inc. (HEPA) Insider Trading

4 insiders at Hepion Pharmaceuticals, Inc. (HEPA) have purchased stock in the past 90 days, totaling $400K across 5 transactions (10,000,000 shares).

The most recent purchase was by Executive Chairman LoPriore Vincent S on April 21, 2026 — a $200K buy of 5,000,000 shares at $0.04, bringing his total holdings to 5,000,000 shares.

Insiders who purchased: LoPriore Vincent S (Executive Chairman, 2 buys totaling $250K); Stetz Gary S. (CEO, 1 buy totaling $50K); Appajosyula Sireesh (Director, 1 buy totaling $50K); Purcell Michael J. (Director, 1 buy totaling $50K).

This insider buying is notable given that HEPA had no recorded open market purchases in the nine months before that.

HEPA is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $2M.

With 4 different insiders buying in the same 90-day window, this qualifies as cluster buying at HEPA — a pattern that research suggests can signal conviction among management.

Track HEPA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.